$3.07
-0.30-8.9%
Armata Pharmaceuticals Inc
ARMPAMEX
Armata Pharmaceuticals (ARMP) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.45 | $-0.39 | $-0.19 | $-0.42 |
| Actual | $-0.27 | $-3.16 | $-3.43 | $-0.74 |
| Surprise | +40.0% | -710.3% | -1705.3% | -76.2% |
| Revenue | ||||
| Estimate | $504000 | — | $1.0M | $1.4M |
| Actual | $2.5M | $789000 | $1.1M | $1.2M |
| Surprise | +398.0% | — | +4.73% | -16.0% |
| Metric | Q3 '26E | Q4 '26E |
|---|---|---|
| Earnings Per Share (Non-GAAP) | ||
| Consensus | $-0.56 | $-0.43 |
| Revenue | ||
| Consensus | $540000 | $618000 |
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q2 | Aug 12, 2026 | $-0.27 | $-0.45 | 40.0 % |
| Q1 | May 13, 2026 | $-3.16 | $-0.39 | -710.3 % |
| Q4 | Mar 25, 2026 | $-3.43 | $-0.19 | -1705.3 % |
| Q3 | Nov 12, 2025 | $-0.74 | $-0.42 | -76.2 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q2 | Aug 12, 2026 | $2.51M | $504.00K | 398.0 % |
| Q4 | Mar 25, 2026 | $1.09M | $1.04M | 4.73 % |
| Q3 | Nov 12, 2025 | $1.16M | $1.38M | -16.0 % |
| Q2 | Aug 12, 2025 | $2.17M | $1.38M | 57.2 % |
